262 related articles for article (PubMed ID: 36376318)
1. Metagenomics of Parkinson's disease implicates the gut microbiome in multiple disease mechanisms.
Wallen ZD; Demirkan A; Twa G; Cohen G; Dean MN; Standaert DG; Sampson TR; Payami H
Nat Commun; 2022 Nov; 13(1):6958. PubMed ID: 36376318
[TBL] [Abstract][Full Text] [Related]
2. Integrated Multi-Cohort Analysis of the Parkinson's Disease Gut Metagenome.
Boktor JC; Sharon G; Verhagen Metman LA; Hall DA; Engen PA; Zreloff Z; Hakim DJ; Bostick JW; Ousey J; Lange D; Humphrey G; Ackermann G; Carlin M; Knight R; Keshavarzian A; Mazmanian SK
Mov Disord; 2023 Mar; 38(3):399-409. PubMed ID: 36691982
[TBL] [Abstract][Full Text] [Related]
3. Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome.
Hill-Burns EM; Debelius JW; Morton JT; Wissemann WT; Lewis MR; Wallen ZD; Peddada SD; Factor SA; Molho E; Zabetian CP; Knight R; Payami H
Mov Disord; 2017 May; 32(5):739-749. PubMed ID: 28195358
[TBL] [Abstract][Full Text] [Related]
4. Gut metagenomics-derived genes as potential biomarkers of Parkinson's disease.
Qian Y; Yang X; Xu S; Huang P; Li B; Du J; He Y; Su B; Xu LM; Wang L; Huang R; Chen S; Xiao Q
Brain; 2020 Aug; 143(8):2474-2489. PubMed ID: 32844199
[TBL] [Abstract][Full Text] [Related]
5. Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal Changes.
Palacios N; Wilkinson J; Bjornevik K; Schwarzschild MA; McIver L; Ascherio A; Huttenhower C
Ann Neurol; 2023 Sep; 94(3):486-501. PubMed ID: 37314861
[TBL] [Abstract][Full Text] [Related]
6. Systematic analysis of gut microbiome reveals the role of bacterial folate and homocysteine metabolism in Parkinson's disease.
Rosario D; Bidkhori G; Lee S; Bedarf J; Hildebrand F; Le Chatelier E; Uhlen M; Ehrlich SD; Proctor G; Wüllner U; Mardinoglu A; Shoaie S
Cell Rep; 2021 Mar; 34(9):108807. PubMed ID: 33657381
[TBL] [Abstract][Full Text] [Related]
7. Exploring human-genome gut-microbiome interaction in Parkinson's disease.
Wallen ZD; Stone WJ; Factor SA; Molho E; Zabetian CP; Standaert DG; Payami H
NPJ Parkinsons Dis; 2021 Aug; 7(1):74. PubMed ID: 34408160
[TBL] [Abstract][Full Text] [Related]
8. Gut microbial determinants of clinically important improvement in patients with rheumatoid arthritis.
Gupta VK; Cunningham KY; Hur B; Bakshi U; Huang H; Warrington KJ; Taneja V; Myasoedova E; Davis JM; Sung J
Genome Med; 2021 Sep; 13(1):149. PubMed ID: 34517888
[TBL] [Abstract][Full Text] [Related]
9. Altered gut microbiota in Parkinson's disease patients/healthy spouses and its association with clinical features.
Zhang F; Yue L; Fang X; Wang G; Li C; Sun X; Jia X; Yang J; Song J; Zhang Y; Guo C; Ma G; Sang M; Chen F; Wang P
Parkinsonism Relat Disord; 2020 Dec; 81():84-88. PubMed ID: 33099131
[TBL] [Abstract][Full Text] [Related]
10. Implications of the Gut Microbiome in Parkinson's Disease.
Elfil M; Kamel S; Kandil M; Koo BB; Schaefer SM
Mov Disord; 2020 Jun; 35(6):921-933. PubMed ID: 32092186
[TBL] [Abstract][Full Text] [Related]
11. Parkinson's Disease and the Gut Microbiome in Rural California.
Zhang K; Paul KC; Jacobs JP; Chou HL; Duarte Folle A; Del Rosario I; Yu Y; Bronstein JM; Keener AM; Ritz B
J Parkinsons Dis; 2022; 12(8):2441-2452. PubMed ID: 36442206
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Fecal Collection Methods on Variation in Gut Metagenomics and Untargeted Metabolomics.
Guan H; Pu Y; Liu C; Lou T; Tan S; Kong M; Sun Z; Mei Z; Qi Q; Quan Z; Zhao G; Zheng Y
mSphere; 2021 Oct; 6(5):e0063621. PubMed ID: 34523982
[TBL] [Abstract][Full Text] [Related]
13. The link between the gut microbiota and Parkinson's Disease: A systematic mechanism review with focus on α-synuclein transport.
Nielsen SD; Pearson NM; Seidler K
Brain Res; 2021 Oct; 1769():147609. PubMed ID: 34371014
[TBL] [Abstract][Full Text] [Related]
14. Multiomic Strategies Reveal Diversity and Important Functional Aspects of Human Gut Microbiome.
Ranjan R; Rani A; Finn PW; Perkins DL
Biomed Res Int; 2018; 2018():6074918. PubMed ID: 30584534
[TBL] [Abstract][Full Text] [Related]
15. The Effects of an Environmentally Relevant Level of Arsenic on the Gut Microbiome and Its Functional Metagenome.
Chi L; Bian X; Gao B; Tu P; Ru H; Lu K
Toxicol Sci; 2017 Dec; 160(2):193-204. PubMed ID: 28973555
[TBL] [Abstract][Full Text] [Related]
16. Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens.
Wallen ZD; Appah M; Dean MN; Sesler CL; Factor SA; Molho E; Zabetian CP; Standaert DG; Payami H
NPJ Parkinsons Dis; 2020; 6():11. PubMed ID: 32566740
[TBL] [Abstract][Full Text] [Related]
17. Metagenome-wide association study revealed disease-specific landscape of the gut microbiome of systemic lupus erythematosus in Japanese.
Tomofuji Y; Maeda Y; Oguro-Igashira E; Kishikawa T; Yamamoto K; Sonehara K; Motooka D; Matsumoto Y; Matsuoka H; Yoshimura M; Yagita M; Nii T; Ohshima S; Nakamura S; Inohara H; Takeda K; Kumanogoh A; Okada Y
Ann Rheum Dis; 2021 Dec; 80(12):1575-1583. PubMed ID: 34426398
[TBL] [Abstract][Full Text] [Related]
18. Human gut microbiota and Parkinson's disease.
Pant A; Bisht KS; Aggarwal S; Maiti TK
Prog Mol Biol Transl Sci; 2022; 192(1):281-307. PubMed ID: 36280322
[TBL] [Abstract][Full Text] [Related]
19. Early Dysbiosis and Dampened Gut Microbe Oscillation Precede Motor Dysfunction and Neuropathology in Animal Models of Parkinson's Disease.
Liang F; Chen CY; Li YP; Ke YC; Ho EP; Jeng CF; Lin CH; Chen SK
J Parkinsons Dis; 2022; 12(8):2423-2440. PubMed ID: 36155528
[TBL] [Abstract][Full Text] [Related]
20. Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson's disease patients.
Bedarf JR; Hildebrand F; Coelho LP; Sunagawa S; Bahram M; Goeser F; Bork P; Wüllner U
Genome Med; 2017 Apr; 9(1):39. PubMed ID: 28449715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
